Press Releases | Today in Medicine

URGN Class Action News: UroGen Pharma Ltd. Investors with Large Losses Should Contact Robbins LLP Before July 28 for Information About Leading the Class Action

GlobeNewswire, Inc. · July 17, 2025

SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15,...

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action– Hagens Berman

GlobeNewswire, Inc. · July 17, 2025

SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- When, on May 27, 2025, Rocket Pharmaceuticals (NASDAQ: RCKT) revealed that the FDA put a clinical hold on its Phase 2 pivotal trial for RP-A501, an experimental therapy intended to treat patients...

RxLogic Launches SmartBytes Digital Newsletter, Delivers Insights into Smarter Pharmacy Benefit Management

GlobeNewswire, Inc. · July 17, 2025

NASHVILLE, Tenn., July 17, 2025 (GLOBE NEWSWIRE) -- RxLogic, a leading technology company for pharmacy benefit claims processing that provides a SaaS-based platform of smart adjudication solutions, is proud to announce the launch of SmartBytes,...

Dr. Michael Rimlawi Announces National Scholarship for Aspiring Physicians, Supporting Future Leaders in Medicine

GlobeNewswire, Inc. · July 17, 2025

DALLAS, July 17, 2025 (GLOBE NEWSWIRE) -- The Dr. Michael Rimlawi Scholarship for Future Doctors proudly announces its 2026 application cycle, inviting undergraduate students with aspirations of entering the medical field to apply. Established by...

Dr. Edward Lubin Scholarship for Medical Students Announces New Opportunity to Support Future Healthcare Leaders

GlobeNewswire, Inc. · July 17, 2025

TAMPA, Fla., July 17, 2025 (GLOBE NEWSWIRE) -- The Dr. Edward Lubin Scholarship for Medical Students is now accepting applications for its annual award, designed to support undergraduate students across the United States who are committed to...

Early Alert: Microbore Extension Set Issue from B. Braun Medical Inc.

U.S. Food and Drug Administration · July 17, 2025

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk issue. The FDA will keep the public informed and update this web page as significant new...

Kestra Medical Technologies Wins 2025 Top Workplaces Industry Award, A National Recognition

GlobeNewswire, Inc. · July 17, 2025

KIRKLAND, Wash., July 17, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, announced today that it is a 2025 Top Workplaces Industry winner by Energage, a...

Crucial Data Solutions Names Dr. Leigh J. Mack Chief Medical Officer Amid Industry AI Shift

EIN Presswire · July 17, 2025

RENO, NV, UNITED STATES, July 17, 2025 /⁨EINPresswire.com⁩/ -- Crucial Data Solutions (CDS), provider of the industry’s only end-to-end eClinical platform available as a native mobile app, today announced that Leigh J. Mack, MD, PhD has rejoined...

Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); Hims & Hers, Inc. (NYSE: HIMS); Petco Health & Wellness Company, Inc. (NASDAQ: WOOF); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigating…

GlobeNewswire, Inc. · July 17, 2025

PHILADELPHIA, July 17, 2025 (GLOBE NEWSWIRE) -- Centene Corporation (NYSE: CNC): Grabar Law Office is investigating claims on behalf of shareholders of Centene Corporation (NYSE: CNC). The investigation concerns whether certain officers and...

OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain

GlobeNewswire, Inc. · July 17, 2025

LONDON and NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated...

NASDAQ: RCKT INVESTOR ALERT: Berger Montague Advises Rocket Pharmaceuticals (RCKT) Investors of August 11, 2025 Deadline

GlobeNewswire, Inc. · July 17, 2025

PHILADELPHIA, July 17, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC, a Philadelphia-based law firm focused on investor protection, is investigating claims against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket Pharmaceuticals” or the...

60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria

GlobeNewswire, Inc. · July 17, 2025

Study will evaluate activity of tafenoquine against vector-borne pathogens, Borrelia (Lyme disease) and Bartonella in cell culture Borrelia and Bartonella, together with Babesia, represent the "3Bs," pathogens most often present in individuals...

TWG Announces Entry into a Memorandum of Understanding with Chinese Pharmaceutical Group for Injection of Pet Pharmaceutical Products Business

GlobeNewswire, Inc. · July 17, 2025

Hong Kong, July 17, 2025 (GLOBE NEWSWIRE) -- Top Wealth Group Holding Limited (NASDAQ: TWG) (“Top Wealth” or the “Company”), today announced that it has entered into a legally-binding memorandum of understanding (the “MOU”) with Jilin Xiuzheng...

BioAtla Announces Upcoming Oral Presentation at the 2025 European Society for Medical Oncology (ESMO) TAT Asia Meeting

GlobeNewswire, Inc. · July 17, 2025

SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company” or “BioAtla”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...

BioStem Technologies Provides Comments on CMS CY 2026 Proposed Medicare Reimbursement Rule Changes for Skin Substitutes

GlobeNewswire, Inc. · July 17, 2025

POMPANO BEACH, Fla., July 17, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care,...

Pillbox Health Launches Remote Therapeutic Monitoring (RTM) via PillPal App to Advance Medication Adherence

EIN Presswire · July 17, 2025

Pillbox Health launches RTM via PillPal App—boosting adherence, outcomes & revenue for pharmacies, providers & caregivers. TAMPA, FL, UNITED STATES, July 16, 2025 /⁨EINPresswire.com⁩/ -- Pillbox Health LLC , a pioneer in medical adherence and...

60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering

GlobeNewswire, Inc. · July 16, 2025

WASHINGTON, July 16, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (the “Company” or “60 Degrees”) (Nasdaq: SXTP; SXTPW), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the closing...

Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

GlobeNewswire, Inc. · July 16, 2025

SAN JOSE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will...

Attorney General Dan Rayfield Helps Secure $202 Million Settlement with Gilead Over Kickback Scheme Involving HIV Medications

Oregon Department of Justice · July 16, 2025

Attorney General Dan Rayfield announced today that Oregon has joined a multistate coalition in securing a $202 million settlement in principle with Gilead Sciences, Inc., resolving allegations that the pharmaceutical giant paid illegal kickbacks...

Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025

GlobeNewswire, Inc. · July 16, 2025

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2025 financial results on Wednesday, August 6, 2025 before the U.S. financial markets open. The company will host...